Cas no 61-52-9 (N,N-Dipropyl-1H-indole-3-ethanamine)
N,N-Dipropyl-1H-indole-3-ethanamine Chemical and Physical Properties
Names and Identifiers
-
- N-(2-(1H-Indol-3-yl)ethyl)-N-propylpropan-1-amine
- N,N-DIPROPYLTRYPTAMINE
- N,N-dipropyltryptamine HCl
- N-[2-(1H-indol-3-yl)ethyl]-N-propylpropan-1-amine
- 4-FEC
- (2-Indol-3-yl-aethyl)-dipropyl-amin
- (2-indol-3-yl-ethyl)-dipropyl-amine
- 1H-Indole-3-ethanamine,N,N-dipropyl
- 3-(2-(Dipropylamino)ethyl)indole
- Dipropyltryptamine
- INDOLE,3-(2-(DIPROPYLAMINO)ETHYL)
- BRN 0173122
- C16086
- UNII-S7272VWU50
- DPT [Experimental Drug]
- A833279
- [2-(1H-indol-3-yl)ethyl]dipropylamine
- AKOS015967123
- FT-0629586
- C16H24N2
- D-6500
- CHEMBL1779153
- SCHEMBL1118996
- N,N-Dipropyltryptamine, free base
- 4-22-00-04323 (Beilstein Handbook Reference)
- ADAL1292863
- 1H-Indole-3-ethanamine, N,N-dipropyl-
- DTXSID30209847
- LS-83046
- NCGC00247727-01
- N-[2-(1H-indol-3-yl)ethyl]-N-propyl-propan-1-amine
- MB02028
- 61-52-9
- N,N-Dipropyltryptamine(DPT)
- Q2723010
- BOOQTIHIKDDPRW-UHFFFAOYSA-N
- S7272VWU50
- INDOLE, 3-(2-(DIPROPYLAMINO)ETHYL)-
- N,N-Dipropyl-1H-indole-3-ethanamine
- NS00017419
- indole, 3-(2-dipropylaminoethyl)-
- DPT (Experimental Drug)
- DB-023078
- DTXCID80132338
-
- Inchi： 1S/C16H24N2/c1-3-10-18(11-4-2)12-9-14-13-17-16-8-6-5-7-15(14)16/h5-8,13,17H,3-4,9-12H2,1-2H3
- InChI Key： BOOQTIHIKDDPRW-UHFFFAOYSA-N
- SMILES： N(CCC)(CCC)CCC1=CNC2C=CC=CC1=2
Computed Properties
- Exact Mass: 244.19400
- Monoisotopic Mass: 244.193949
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 18
- Rotatable Bond Count: 7
- Complexity: 223
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4.3
- Topological Polar Surface Area: 19
Experimental Properties
- Density: 1.0±0.1 g/cm3
- Melting Point: NA
- Boiling Point: 387.4±25.0 °C at 760 mmHg
- Flash Point: 188.1±23.2 °C
- Refractive Index: 1.574
- PSA: 19.03000
- LogP: 3.83240
- Vapor Pressure: 0.0±0.9 mmHg at 25°C
N,N-Dipropyl-1H-indole-3-ethanamine Security Information
- Signal Word：warning
- Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement： P264+P280+P305+P351+P338+P337+P313
- Safety Instruction： H303+H313+H333
- Storage Condition：storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
N,N-Dipropyl-1H-indole-3-ethanamine Customs Data
- HS CODE：2933990090
- Customs Data：
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
N,N-Dipropyl-1H-indole-3-ethanamine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | D491825-100mg |
N,N-Dipropyl-1H-indole-3-ethanamine |
61-52-9 | 100mg |
$ 64.00 | 2023-04-17 | ||
| TRC | D491825-250mg |
N,N-Dipropyl-1H-indole-3-ethanamine |
61-52-9 | 250mg |
$ 81.00 | 2023-04-17 | ||
| TRC | D491825-500mg |
N,N-Dipropyl-1H-indole-3-ethanamine |
61-52-9 | 500mg |
$ 121.00 | 2023-04-17 | ||
| TRC | D491825-1g |
N,N-Dipropyl-1H-indole-3-ethanamine |
61-52-9 | 1g |
$ 165.00 | 2022-06-05 | ||
| Chemenu | CM147817-10g |
N-(2-(1H-indol-3-yl)ethyl)-N-propylpropan-1-amine |
61-52-9 | 95% | 10g |
$281 | 2021-08-05 | |
| Chemenu | CM147817-10g |
N-(2-(1H-indol-3-yl)ethyl)-N-propylpropan-1-amine |
61-52-9 | 95% | 10g |
$*** | 2023-03-31 | |
| TRC | D491825-1000mg |
N,N-Dipropyl-1H-indole-3-ethanamine |
61-52-9 | 1g |
$ 201.00 | 2023-04-17 | ||
| 1PlusChem | 1P00EAW2-100mg |
N,N-DIPROPYLTRYPTAMINE |
61-52-9 | 98% | 100mg |
$61.00 | 2024-04-22 | |
| 1PlusChem | 1P00EAW2-500mg |
N,N-DIPROPYLTRYPTAMINE |
61-52-9 | 98% | 500mg |
$146.00 | 2024-04-22 | |
| Aaron | AR00EB4E-100mg |
N,N-DIPROPYLTRYPTAMINE |
61-52-9 | 98% | 100mg |
$56.00 | 2025-02-11 |
N,N-Dipropyl-1H-indole-3-ethanamine Related Literature
-
Manas Mandal,Debasis Ghosh,Soumen Giri,Imran Shakir,Chapal Kumar Das RSC Adv. 2014 4 30832
-
2. Electrically wired mitochondrial electrodes for measuring mitochondrial function for drug screeningRobert L. Arechederra,Abdul Waheed,William S. Sly,Shelley D. Minteer Analyst 2011 136 3747
-
Xiaoyan Wu,Junjie Fan,Chunling Fu,Shengming Ma Chem. Sci. 2019 10 6316
-
Peter B. Baker,Geoffrey F. Phillips Analyst 1983 108 777
Additional information on N,N-Dipropyl-1H-indole-3-ethanamine
Introduction to N,N-Dipropyl-1H-indole-3-ethanamine (CAS No. 61-52-9)
N,N-Dipropyl-1H-indole-3-ethanamine, a compound with the chemical formula C??H??N, is a derivative of indole and has garnered significant attention in the field of pharmaceutical research due to its unique structural and pharmacological properties. This compound is characterized by its indole core substituted with two propyl groups at the nitrogen atom and an ethylamine side chain at the 3-position of the indole ring. The presence of these functional groups imparts distinct chemical reactivity and biological activity, making it a valuable scaffold for drug discovery and development.
The CAS number 61-52-9 provides a unique identifier for this compound, ensuring consistency and accuracy in scientific literature and regulatory filings. This numerical code is essential for distinguishing N,N-Dipropyl-1H-indole-3-ethanamine from other structurally similar compounds, facilitating its use in various research applications.
N,N-Dipropyl-1H-indole-3-ethanamine has been extensively studied for its potential pharmacological effects. Research has shown that this compound exhibits properties that make it a promising candidate for treating various neurological and inflammatory disorders. The indole moiety, known for its presence in many bioactive natural products, contributes to the compound's ability to interact with multiple biological targets.
Recent studies have highlighted the compound's potential in modulating neurotransmitter systems, particularly serotonin and dopamine pathways. These pathways are crucial for regulating mood, cognition, and motor control, making N,N-Dipropyl-1H-indole-3-ethanamine a candidate for therapeutic applications in conditions such as depression, anxiety, and Parkinson's disease. The N,N-dipropyl substitution pattern enhances the lipophilicity of the molecule, improving its ability to cross the blood-brain barrier, which is essential for central nervous system (CNS) drug delivery.
In addition to its neurological effects, N,N-Dipropyl-1H-indole-3-ethanamine has shown promise in anti-inflammatory applications. Chronic inflammation is a hallmark of many diseases, including autoimmune disorders and metabolic syndromes. The compound's ability to inhibit key inflammatory cytokines and enzymes has been demonstrated in preclinical models, suggesting its potential as an anti-inflammatory agent.
The structural features of N,N-Dipropyl-1H-indole-3-ethanamine also make it a versatile scaffold for medicinal chemistry modifications. Researchers have explored various derivatives of this compound to optimize its pharmacological profile. For instance, modifications at the propyl groups or the ethylamine side chain can alter its potency, selectivity, and metabolic stability. These modifications are crucial for developing drug candidates that meet stringent pharmacokinetic and safety requirements.
One of the most compelling aspects of N,N-Dipropyl-1H-indole-3-ethanamine is its synthetic accessibility. The indole core can be readily functionalized using established organic synthesis techniques, allowing for rapid exploration of novel derivatives. This accessibility has enabled researchers to rapidly screen large libraries of compounds for biological activity, accelerating the drug discovery process.
The compound's interaction with biological targets has been further elucidated through computational modeling and structural biology techniques. These studies have provided insights into how N,N-Dipropyl-1H-indole-3-ethanamine binds to its receptors and enzymes, offering a foundation for rational drug design. Understanding these interactions at a molecular level is crucial for optimizing drug candidates and minimizing off-target effects.
Current research is also exploring the potential of N,N-Dipropyl-1H-indole-3-ethanamine in combination therapies. The concept of combining multiple drugs to achieve synergistic effects is gaining traction in oncology and infectious diseases. By pairing N,N-Dipropyl-1H-indole-3-ethanamine with other therapeutic agents, researchers aim to enhance treatment outcomes while reducing side effects.
The pharmaceutical industry has taken note of the promising properties of N,N-Dipropyl-1H-indole-3-ethanamine and is actively investigating its potential for clinical development. Several companies have initiated preclinical studies to evaluate its safety and efficacy in animal models. These studies are critical steps toward translating laboratory findings into viable therapeutic options for patients.
As research continues to uncover new applications for N,N-Dipropyl-1H-indole-3-ethanamine, it is clear that this compound represents a significant opportunity in drug discovery. Its unique structural features, combined with its demonstrated biological activity, make it a valuable tool for developing novel treatments across multiple therapeutic areas.
61-52-9 (N,N-Dipropyl-1H-indole-3-ethanamine) Related Products
- 63938-63-6(1H-Indole-3-ethanamine,N,N-diethyl-, hydrochloride (1:1))
- 15741-77-2(N,\u200bN-\u200bDibutyltryptamine)
- 14780-24-6(DiPT)
- 22120-39-4(N,N-5-Trimethyl-1H-indole-3-ethanamine)
- 94685-68-4(bis(3-indolylethyl)amine)
- 96096-52-5(N-Methyl-N-(1-methylethyl)-1H-indole-3-ethanamine)
- 16382-06-2(DPT Hydrochloride)
- 7558-72-7(N,N-Diethyltryptamine)
- 68677-25-8(2-(1H-indol-3-yl)-N,N-dimethyl-ethanamine)
- 61-51-8(1H-Indole-3-ethanamine,N,N-diethyl-)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier